cbd oil for ttm

10 Biggest Canadian Marijuana Companies

APHA.TO, WEED.TO, and ACB.TO top the list of biggest Canadian marijuana firms

Eric is currently a duly licensed Independent Insurance Broker licensed in Life, Health, Property, and Casualty insurance. He has worked more than 13 years in both public and private accounting jobs and more than four years licensed as an insurance producer. His background in tax accounting has served as a solid base supporting his current book of business.

The Canadian cannabis industry has grown dramatically in size since the national government legalized cannabis in 2018. Companies in the marijuana industry are involved in the cultivation, growth, and distribution of cannabis and related products for both recreational and medical use. Many new entrants to the industry have done so by investing in cannabis businesses or by launching new cannabis or cannabis-related divisions.

Investors are carefully scrutinizing Canadian cannabis companies' underlying financials to determine which ones offer the best growth on a sustained basis. That focus is especially true since many of these are young companies that launched on their rapid-growth path in the few years since legalization. Many of them are continuing to generate major losses as they focus on developing new products, and expanding their markets through internal growth and acquisitions. As a result, these companies' prospects are measured mainly by revenue growth rather than net income growth. We detail below the 10 biggest Canadian cannabis companies ranked by 12-month trailing revenue. This list is limited to companies which are publicly traded in the U.S. or Canada, either directly or through ADRs. Some foreign companies may report semiannually, and so may have longer lag times. All data throughout is courtesy of YCharts and as of April 2, 2021.

#1 Aphria Inc. (APHA.TO)

  • Revenue (TTM): CA$601.3 million
  • Net Income (TTM): -CA$218.8 million
  • Market Cap: CA$7.2 billion
  • 1-Year Trailing Total Return: 465.9%
  • Exchange: Toronto Stock Exchange

Aphria produces, grows, and markets primarily medical cannabis products. Its medical cannabis is 100% greenhouse grown, allowing its plants to benefit from natural sunlight. The Canadian company’s products include oils, softgels, oral sprays, and cartridges. Aphria is in the process of merging with Tilray Inc. to create the world’s largest cannabis company by pro forma revenue. Aphria also trades in the U.S. under APHA.

#2 Canopy Growth Corp. (WEED.TO)

  • Revenue (TTM): CA$506.1 million
  • Net Income (TTM): -CA$2.3 billion
  • Market Cap: CA$15.4 billion
  • 1-Year Trailing Total Return: 108.9%
  • Exchange: Toronto Stock Exchange

Canopy Growth, headquartered in Canada, produces medical marijuana products. The company has the distinction of having been the first federally-regulated and licensed publicly-traded cannabis grower in North America. It is among the largest cannabis companies in the world by market capitalization. Canopy Growth also trades in the U.S. under CGC.

#3 Aurora Cannabis Inc. (ACB.TO)

  • Revenue (TTM): CA$283.1 million
  • Net Income (TTM): -CA$2.4 billion
  • Market Cap: CA$2.3 billion
  • 1-Year Trailing Total Return: -17.5%
  • Exchange: Toronto Stock Exchange

Aurora Cannabis is a major cannabis producer and a licensed distributor. The company, based in Canada, has operations in both the medical and consumer cannabis areas and has a division focused on cannabidiol products (CBD) for distribution in the U.S. CBD is one of the most active and prevalent ingredients in cannabis. Aurora Cannabis also trades in the U.S. under ACB.

#4 Village Farms International Inc. (VFF.TO)

  • Revenue (TTM): CA$228.0 million
  • Net Income (TTM): CA$15.3 million
  • Market Cap: CA$1.4 billion
  • 1-Year Trailing Total Return: 377.4%
  • Exchange: Toronto Stock Exchange

Village Farms International is a greenhouse grower that sells a variety of produce to grocers in the U.S. and Canada. The Canada-based company operates a cannabis business through its wholly-owned subsidiary, Pure Sunfarms. It has established a joint venture called Village Fields Hemp USA, LLC, to cultivate hemp and extract CBD for sale in the U.S. Village Farms International also trades in the U.S. under VFF.

#5 Tilray Inc. (TLRY)

  • Revenue (TTM): $210.5 million
  • Net Income (TTM): -$271.1 million
  • Market Cap: $3.8 billion
  • 1-Year Trailing Total Return: 278.6%
  • Exchange: NASDAQ

Tilray is a Canada-based company focused primarily on cultivating, processing, and distribution of medical cannabis products. The company also is heavily focused on medical cannabis research. Its products include dried cannabis and cannabis extracts. As mentioned, Tilray and Aphria plan to merge. While Tilray is a Canadian company, it only trades on the NASDAQ exchange.

#6 Ayr Wellness Inc. (AYR.A.CX)

  • Revenue (TTM): CA$207.0 million
  • Net Income (TTM): -CA$231.0 million
  • Market Cap: CA$1.5 billion
  • 1-Year Trailing Total Return: 317.8%
  • Exchange: Canadian Securities Exchange

Ayr Wellness cultivates, manufactures, and distributes a broad range of cannabis and related products. Based in Canada, the company offers brands including Kynd, Sira Naturals, Jimmy's Choice, cannabis-based vape products line Entourage.

#7 TerrAscend Corp. (TER.CX)

  • Revenue (TTM): CA$198.3 million
  • Net Income (TTM): -CA$155.1 million
  • Market Cap: CA$2.2 billion
  • 1-Year Trailing Total Return: 403.3%
  • Exchange: Canadian Securities Exchange

TerrAscend is an integrated Canadian cannabis company offering products for both medical and recreational use. The company has a portfolio of business including: Arise Bioscience Inc., a manufacturer and distributor of hemp products; The Apothecarium, a cannabis dispensary; and Ilera Healthcare, a medical marijuana cultivator, processor, and distributor; as well as others.

#8 HEXO Corp. (HEXO.TO)

  • Revenue (TTM): CA$111.6 million
  • Net Income (TTM): -CA$213.1 million
  • Market Cap: CA$993.8 million
  • 1-Year Trailing Total Return: 105.1%
  • Exchange: Toronto Stock Exchange
See also  cbd oil for ms reviews

HEXO was founded in 2013 to serve the Canadian medical cannabis market and expanded to serve the adult-use recreational market following nationwide legalization. The consumer packaged goods cannabis company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. The company also trades in the U.S. under HEXO.

#9 Fire & Flower Holdings Corp. (FAF.TO)

  • Revenue (TTM): CA$101.6 million
  • Net Income (TTM): -CA$89.8 million
  • Market Cap: CA$272.3 million
  • 1-Year Trailing Total Return: 185.0%
  • Exchange: Toronto Stock Exchange

Fire & Flower Holdings, through its subsidiary Fire & Flower Inc., operates an independent retail store selling cannabis products for recreational use. The company's digital platform, Hifyre, connects consumers with a range of cannabis products. Fire & Flower has dozens of retail locations throughout Alberta, Manitoba, Ontario, Saskatchewan, and Yukon.

#10 Zenabis Global Inc. (ZENA.TO)

  • Revenue (TTM): CA$88.9 million
  • Net Income (TTM): -CA$130.8 million
  • Market Cap: CA$96.5 million
  • 1-Year Trailing Total Return: 60.0%
  • Exchange: Toronto Stock Exchange

Zenabis Global cultivates and sells cannabis products for both recreational and medical use. The company sells under the brand name Zenabis for medical cannabis products, and under the brand names Namaste, Re-Up, and Blazery, for recreational-use products. Zenabis operates millions of square feet of combined greenhouse and indoor facility space across Canada.

Tenet Healthcare (THC)

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.37%
2 Buy 18.89%
3 Hold 10.41%
4 Sell 6.06%
5 Strong Sell 2.90%
S&P 500 11.48%

Zacks Rank Education – Learn about the Zacks Rank

Zacks Rank Home – Zacks Rank resources in one place

Zacks Premium – The only way to fully access the Zacks Rank

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education – Learn more about the Zacks Style Scores

A Value | C Growth | B Momentum | A VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education — Learn more about the Zacks Rank
Zacks Industry Rank Education — Learn more about the Zacks Industry Rank

Fundamental Charts

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It’s packed with all of the company’s key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company’s vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

About PE Ratio (TTM)

Tenet Healthcare Corporation has a trailing-twelve-months P/E of 10.69X compared to the Medical – Hospital industry’s P/E of 10.69X.

Price to Earnings Ratio or P/E is price / earnings. It is the most commonly used metric for determining a company’s value relative to its earnings. In this example, we are using the actual earnings (EPS) for the trailing twelve months (or TTM). A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its trailing twelve months earnings. In general, a lower number or multiple is usually considered better than a higher one.

THC 83.94 +2.91(3.59%)

Will THC be a Portfolio Killer in February?

Zacks Investment Research is releasing its prediction for THC based on the 1-3 month trading system that nearly triples the S&P 500.

Zacks News for THC

Ensign Group (ENSG) Q4 Earnings Match Estimates, Rise Y/Y

Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Surge Y/Y

THC: What are Zacks experts saying now?

Zacks Private Portfolio Services

Tenet Healthcare (THC) Q4 Earnings Beat Estimates

Ensign Group (ENSG) Buys Facilities to Expand in California

Tenet Healthcare (THC) Q4 Earnings Preview: What’s in the Cards?

Other News for THC

Tamarack Advisers, LP Buys Tenet Healthcare Corp, Humana Inc, Biomarin Pharmaceutical Inc, .

Sectoral Asset Management Inc Buys Mirati Therapeutics Inc, Privia Health Group Inc, Certara .

Tenet Healthcare Corporation 2021 Q4 – Results – Earnings Call Presentation

Capital Growth Management LP Buys Builders FirstSource Inc, Tenet Healthcare Corp, Lennar Corp, .

Tenet Healthcare extends gains after adding another bull at UBS on earnings

Quick Links

Services

My Account

Resources

Client Support

Follow Us

Zacks Mobile App

Zacks Research is Reported On:

  • MSN
  • Marketwatch
  • Nasdaq
  • Forbes
  • Investors.com
  • Morningstar

This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor’s Business Daily, Inc.; and Morningstar, Inc.

Copyright 2022 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +25.37% per year. These returns cover a period from January 1, 1988 through January 3, 2022. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.

Visit Performance Disclosure for information about the performance numbers displayed above.

Visit www.zacksdata.com to get our data and content for your mobile app or website.

Real time prices by BATS. Delayed quotes by Sungard.

NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tenet Healthcare (THC)

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.37%
2 Buy 18.89%
3 Hold 10.41%
4 Sell 6.06%
5 Strong Sell 2.90%
S&P 500 11.48%

Zacks Rank Education – Learn about the Zacks Rank

Zacks Rank Home – Zacks Rank resources in one place

Zacks Premium – The only way to fully access the Zacks Rank

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education – Learn more about the Zacks Style Scores

A Value | C Growth | B Momentum | A VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education — Learn more about the Zacks Rank
Zacks Industry Rank Education — Learn more about the Zacks Industry Rank

Fundamental Charts

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It’s packed with all of the company’s key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company’s vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

About Return on Equity (TTM)

Tenet Healthcare Corporation’s return on equity, or ROE, is 56.04% compared to the ROE of the Medical – Hospital industry of 16.41%. While this shows that THC makes good use of its equity, this metric will vary significantly from industry to industry.

Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company’s Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.

THC 83.94 +2.91(3.59%)

Will THC be a Portfolio Killer in February?

Zacks Investment Research is releasing its prediction for THC based on the 1-3 month trading system that nearly triples the S&P 500.

Zacks News for THC

Ensign Group (ENSG) Q4 Earnings Match Estimates, Rise Y/Y

Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Surge Y/Y

THC: What are Zacks experts saying now?

Zacks Private Portfolio Services

Tenet Healthcare (THC) Q4 Earnings Beat Estimates

Ensign Group (ENSG) Buys Facilities to Expand in California

Tenet Healthcare (THC) Q4 Earnings Preview: What’s in the Cards?

Other News for THC

Tamarack Advisers, LP Buys Tenet Healthcare Corp, Humana Inc, Biomarin Pharmaceutical Inc, .

Sectoral Asset Management Inc Buys Mirati Therapeutics Inc, Privia Health Group Inc, Certara .

Tenet Healthcare Corporation 2021 Q4 – Results – Earnings Call Presentation

Capital Growth Management LP Buys Builders FirstSource Inc, Tenet Healthcare Corp, Lennar Corp, .

Tenet Healthcare extends gains after adding another bull at UBS on earnings

Quick Links

Services

My Account

Resources

Client Support

Follow Us

Zacks Mobile App

Zacks Research is Reported On:

  • MSN
  • Marketwatch
  • Nasdaq
  • Forbes
  • Investors.com
  • Morningstar

This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor’s Business Daily, Inc.; and Morningstar, Inc.

Copyright 2022 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +25.37% per year. These returns cover a period from January 1, 1988 through January 3, 2022. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.

Visit Performance Disclosure for information about the performance numbers displayed above.

Visit www.zacksdata.com to get our data and content for your mobile app or website.

Real time prices by BATS. Delayed quotes by Sungard.

NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

See also  how to use cbd oil for the first time